» Articles » PMID: 3118640

Standardization of a Chemiluminescence Method for the Measurement of Meningococcal Opsonins Using Ethanol Fixed Meningococci

Overview
Date 1987 Aug 1
PMID 3118640
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A chemiluminescence (CL) method using polymorphonuclear leukocytes (PMNLs) and an automatic photoluminometer was used to measure serum opsonins to viable and inactivated group B meningococci. Continuous mixing at 37 degrees C both during opsonization and phagocytosis was essential for optimal CL responses. The CL response increased rapidly during an opsonization time up to 7.5 min, and with PMNL and bacteria concentrations up to 37.5 X 10(5) and 3.8 X 10(7) cells/ml, respectively. Opsonized ethanol fixed meningococci gave CL responses similar to those of viable meningococci, but had a better reproducibility. Using the ethanol fixed bacteria, the variation of PMNLs from different donors, the day-to-day variation, and the coefficient of variation of the CL responses, were all less than 10%. The opsonic activity of convalescent sera from 10 patients with meningococcal disease was markedly higher than that of sera obtained during the acute phase of the disease. Thus, this standardized CL assay using ethanol fixed bacteria is a highly reproducible and sensitive method for measuring serum opsonins to meningococci.

Citing Articles

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.

Plested J, Ferry B, Coull P, Makepeace K, Lehmann A, MacKinnon F Infect Immun. 2001; 69(5):3203-13.

PMID: 11292742 PMC: 98278. DOI: 10.1128/IAI.69.5.3203-3213.2001.


Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies.

Verheul A, Kuipers A, Braat A, Dekker H, Peeters C, Snippe H Clin Diagn Lab Immunol. 1994; 1(6):729-36.

PMID: 8556528 PMC: 368403. DOI: 10.1128/cdli.1.6.729-736.1994.


Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine.

Aase A, Bjune G, Hoiby E, Rosenqvist E, Pedersen A, Michaelsen T Infect Immun. 1995; 63(9):3531-6.

PMID: 7642288 PMC: 173489. DOI: 10.1128/iai.63.9.3531-3536.1995.


Cross-reacting serum opsonins in patients with meningococcal disease.

Guttormsen H, Bjerknes R, Naess A, Lehmann V, Halstensen A, Sornes S Infect Immun. 1992; 60(7):2777-83.

PMID: 1612745 PMC: 257234. DOI: 10.1128/iai.60.7.2777-2783.1992.